CRONOS GROUP INC (CRON.CA) Stock Price, Quote, News and Overview
TSX:CRON - Toronto Stock Exchange - CA22717L1013 - Common Stock - Currency: CAD
CRON.CA Quote, Performance and Key Statistics
TSX:CRON (8/6/2025, 7:00:00 PM)
2.88
+0.05 (+1.77%)
The current stock price of CRON.CA is 2.88 CAD. In the past month the price increased by 1.41%. In the past year, price decreased by -4.95%.
CRON.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BHC.CA | BAUSCH HEALTH COS INC | 1.52 | 2.93B | ||
| TLRY.CA | TILRAY BRANDS INC | N/A | 935.45M | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 6.73 | 795.87M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | 57.18 | 626.80M | ||
| DHT-U.CA | DRI HEALTHCARE TRUST | 4.81 | 568.88M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 333.23M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 25.7 | 329.22M | ||
| ACB.CA | AURORA CANNABIS INC | N/A | 326.81M | ||
| OGI.CA | ORGANIGRAM GLOBAL INC | 32 | 257.05M | ||
| HITI.CA | HIGH TIDE INC | N/A | 245.22M | ||
| TSND.CA | TERRASCEND CORP | N/A | 243.94M | ||
| NGEN.CA | NERVGEN PHARMA CORP | N/A | 225.96M |
Related stock screener links
About CRON.CA
Company Profile
Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The firm operates through one segment, which is comprised of operations in Canada and Israel and is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s international brand portfolio includes Spinach, PEACE NATURALS, and Lord Jones. The Spinach brand offers pre-rolls infused with cold-filtered cannabis extract and coated in kief, and all-in-one disposable vapes. The Lord Jones is a hemp-derived cannabidiol (CBD) brand. Its Lord Jones Hash Fusions are a line-up of premium ice water hash infused pre-rolls. This brand also offers vapes and edibles. Its PEACE NATURALS offer Peppermint CBD, a blend of CBD extract, quality medium-chain triglycerides (MCT) oil, and a hint of natural peppermint flavor.
Company Info
CRONOS GROUP INC
4491 Concession Rd 12
TORONTO ONTARIO M5V2G9 CA
CEO: Kurt T. Schmidt
Employees: 626
Phone: 14165040004
CRONOS GROUP INC / CRON.CA FAQ
What is the stock price of CRONOS GROUP INC today?
The current stock price of CRON.CA is 2.88 CAD. The price increased by 1.77% in the last trading session.
What is the ticker symbol for CRONOS GROUP INC stock?
The exchange symbol of CRONOS GROUP INC is CRON and it is listed on the Toronto Stock Exchange exchange.
On which exchange is CRON.CA stock listed?
CRON.CA stock is listed on the Toronto Stock Exchange exchange.
What is the price forecast or stock price prediction for CRONOS GROUP INC stock?
10 analysts have analysed CRON.CA and the average price target is 2.4 CAD. This implies a price decrease of -16.77% is expected in the next year compared to the current price of 2.88. Check the CRONOS GROUP INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CRONOS GROUP INC worth?
CRONOS GROUP INC (CRON.CA) has a market capitalization of 1.11B CAD. This makes CRON.CA a Small Cap stock.
How many employees does CRONOS GROUP INC have?
CRONOS GROUP INC (CRON.CA) currently has 626 employees.
What are the support and resistance levels for CRONOS GROUP INC (CRON.CA) stock?
CRONOS GROUP INC (CRON.CA) has a support level at 2.86 and a resistance level at 2.91. Check the full technical report for a detailed analysis of CRON.CA support and resistance levels.
Is CRONOS GROUP INC (CRON.CA) expected to grow?
The Revenue of CRONOS GROUP INC (CRON.CA) is expected to grow by 20.49% in the next year. Check the estimates tab for more information on the CRON.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy CRONOS GROUP INC (CRON.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CRON.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CRON.CA, evaluating the profitability, health, valuation and growth aspects
- CRONOS GROUP INC (CRON.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CRONOS GROUP INC (CRON.CA) Sales and EPS estimates to see what analysts future expectations are.
- CRONOS GROUP INC (CRON.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CRONOS GROUP INC (CRON.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- CRONOS GROUP INC (CRON.CA) Stock Chart to make your own analysis
- CRONOS GROUP INC (CRON.CA) Latest news and press-releases to stay up to date.
Does CRONOS GROUP INC (CRON.CA) stock pay dividends?
CRON.CA does not pay a dividend.
When does CRONOS GROUP INC (CRON.CA) report earnings?
CRONOS GROUP INC (CRON.CA) will report earnings on 2025-08-07, before the market open.
What is the Price/Earnings (PE) ratio of CRONOS GROUP INC (CRON.CA)?
The PE ratio for CRONOS GROUP INC (CRON.CA) is 16. This is based on the reported non-GAAP earnings per share of 0.18 and the current share price of 2.88 CAD. Check the full fundamental report for a full analysis of the valuation metrics for CRON.CA.
CRON.CA Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to CRON.CA. When comparing the yearly performance of all stocks, CRON.CA is a bad performer in the overall market: 75.67% of all stocks are doing better.
CRON.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to CRON.CA. While CRON.CA has a great health rating, there are worries on its profitability.
CRON.CA Financial Highlights
Over the last trailing twelve months CRON.CA reported a non-GAAP Earnings per Share(EPS) of 0.18. The EPS increased by 285.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 39.68% | ||
| ROA | 4.29% | ||
| ROE | 4.64% | ||
| Debt/Equity | 0 |
CRON.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 76% to CRON.CA. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of -144.2% and a revenue growth 20.49% for CRON.CA